KalVista Pharmaceuticals Inc. (4XC1)
Market Open
4 Jun, 06:33
XSTU 
€
22. 63
-0.55
-2.3727%
€
- Market Cap
- P/E Ratio
- Div Yield
150 Volume
-2.92 Eps
€ 23.18
Previous Close Want to track 4XC1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
4XC1 Earnings Reports FAQ
What is the earnings per share (EPS) for 4XC1?
The current EPS is -2.92.
What is the company's earnings growth rate?
KalVista Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
KalVista Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for KalVista Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 4XC1 at this time, as KalVista Pharmaceuticals Inc has no recent EPS data to calculate it.
